90 related articles for article (PubMed ID: 9384140)
1. Insulin pump therapy. Situations and solutions.
Lavin-Tompkins J
Lippincotts Prim Care Pract; 1997; 1(5):519-26. PubMed ID: 9384140
[TBL] [Abstract][Full Text] [Related]
2. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
Mozdzan M; Ruxer J; Loba J
Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
[TBL] [Abstract][Full Text] [Related]
3. Update on insulin pump therapy.
Marschilok C
School Nurse News; 2007 Jan; 24(1):12-3. PubMed ID: 17283701
[No Abstract] [Full Text] [Related]
4. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
5. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
6. Intensive insulin therapy and insulin pumps.
Bode BW
Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
[TBL] [Abstract][Full Text] [Related]
7. Insulin pump therapy in childhood diabetes-cost implications for Primary Care Trusts.
Feltbower RG; Campbell FM; Bodansky HJ; Stephenson CR; McKinney PA
Diabet Med; 2006 Jan; 23(1):86-9. PubMed ID: 16409571
[TBL] [Abstract][Full Text] [Related]
8. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
9. Insulin pumps: from inception to the present and toward the future.
Alsaleh FM; Smith FJ; Keady S; Taylor KM
J Clin Pharm Ther; 2010 Apr; 35(2):127-38. PubMed ID: 20456732
[TBL] [Abstract][Full Text] [Related]
10. Patient tips from industry. Benefits of pump therapy.
Diabetes Educ; 2004; 30(2):257. PubMed ID: 15095515
[No Abstract] [Full Text] [Related]
11. [Ambulatory management of patients with external insulin pumps].
Toury I; Hurault C
Soins; 2002 Sep; (668):23-4. PubMed ID: 12271773
[No Abstract] [Full Text] [Related]
12. [Insulin pump treatment is a growing form of therapy].
Nørgaard K
Ugeskr Laeger; 2012 Sep; 174(39):2283. PubMed ID: 23006219
[No Abstract] [Full Text] [Related]
13. Integrating innovative tools into the management of type 2 diabetes to improve patient self-management.
Kruger DF
J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():17-20. PubMed ID: 19402256
[No Abstract] [Full Text] [Related]
14. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
15. Using insulin pump therapy to achieve normoglycemia.
Van Buren PD
JAAPA; 2003 Jul; 16(7):33-6. PubMed ID: 14968497
[No Abstract] [Full Text] [Related]
16. Insulin pump access issues for visually impaired people with type 1 diabetes.
Marom L
Diabetes Res Clin Pract; 2010 Jul; 89(1):e13-5. PubMed ID: 20444517
[TBL] [Abstract][Full Text] [Related]
17. Management of the hospitalized diabetes patient with an insulin pump.
McCrea D
Crit Care Nurs Clin North Am; 2013 Mar; 25(1):111-21. PubMed ID: 23410650
[TBL] [Abstract][Full Text] [Related]
18. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
Weintrob N; Shalitin S; Phillip M
Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
[TBL] [Abstract][Full Text] [Related]
19. A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery.
Scavini M; Hammarberg B; Dosio F; Torri M; Petrella G; Galimberti G; Vai S; Fazio F; Pozza G
Artif Organs; 1997 May; 21(5):405-8. PubMed ID: 9129773
[TBL] [Abstract][Full Text] [Related]
20. Implantable pump therapy restores metabolic control and quality of life in type 1 diabetic patients with Buschke's nonsystemic scleroderma.
Baillot-Rudoni S; Apostol D; Vaillant G; Brun JM; Renard E;
Diabetes Care; 2006 Jul; 29(7):1710. PubMed ID: 16801609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
